Back to
UBS Group AG
AKBA30 quarters
Position history for
UBS Group AG's holdings in AKEBIA THERAPEUTICS INC
Yes. Ubs holds 1,374,950 shares of AKBA (Akebia Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 605,479 shares (+78.7%) from Q1 2026. Ubs has held AKBA in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$1.6M
Current Shares
1.4M
Total Value Change
+$356,442
Total Shares Change
+1.2M
Quarter-by-Quarter History
Other major holders of AKBA: BAUPOST GROUP LLC/MA